Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

IM Cannabis (IMCC) EBITDA: 2019-2025

Historic EBITDA for IM Cannabis (IMCC) over the last 6 years, with Sep 2025 value amounting to -$3.5 million.

  • IM Cannabis' EBITDA fell 215.68% to -$3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.4 million, marking a year-over-year decrease of 40.32%. This contributed to the annual value of -$9.6 million for FY2024, which is 19.91% down from last year.
  • Per IM Cannabis' latest filing, its EBITDA stood at -$3.5 million for Q3 2025, which was down 230.68% from -$1.1 million recorded in Q2 2025.
  • In the past 5 years, IM Cannabis' EBITDA registered a high of $15.5 million during Q2 2022, and its lowest value of -$97.7 million during Q3 2022.
  • Its 3-year average for EBITDA is -$1.5 million, with a median of -$1.4 million in 2023.
  • Within the past 5 years, the most significant YoY rise in IM Cannabis' EBITDA was 488.46% (2022), while the steepest drop was 2,494.96% (2022).
  • Quarterly analysis of 5 years shows IM Cannabis' EBITDA stood at -$13.5 million in 2021, then crashed by 177.12% to -$37.5 million in 2022, then skyrocketed by 91.80% to -$3.1 million in 2023, then grew by 12.10% to -$2.7 million in 2024, then slumped by 215.68% to -$3.5 million in 2025.
  • Its last three reported values are -$3.5 million in Q3 2025, -$1.1 million for Q2 2025, and -$108,719 during Q1 2025.